The Frequency of Depression and the Comorbidity of Psychotic Disorders at Day Hospital of Psychistric Clinic, Clinical Center of Sarajevo University
Alem Cesir, Ifeta Licanin, Saida Fisekovic
Mat Soc Med. 2012; 24(3): 186-189
Introduction: Numerous epidemiological international studies as well as knowledge based on clinical experience show high prevalence and the importance of the psychiatric comorbidity with depressive and anxiety disorders. Goal: The aim of this study is to analyze prevalence of comorbid anxiety disorders and depression in subjects at the Day Hospital of the Psychiatric Clinic, Clinical Center of Sarajevo University (CCUS) and examine the demographic profile of the patients. Material and methods: Study involved 230 randomly selected patients (aged between 18 and 65 years, N=230, who were hospitalized at the Day Hospital of the Psychiatric Clinic of Clinical center of University of Sarajevo from January 1st to December 31st 2011) and who were interviewed by the Structural Clinical Interview (SCID) which generated ICD-X diagnoses and assessment of the comorbidity. Depressive symptoms were assessed by Beck’s Depression Inventory with 28 items. Anxiety symptoms were assessed with Beck’s Anxiety Inventory scale with 21 items. Study is retrospective, clinical and epidemiological. Results: Of the total number of patients (230) it was determined that 107 (46.5%) have depressive episode; 71 (30.9%) anxiety disorder. Comorbidity of these two disorders was found in 14 (6.1%) cases. Anxiety disorders were more represented in women (61.2%), as well as depressive disorders and comorbidity (70.1% and 85.7%). Subjects with depression on average was 52.9±7.4 years old (range 29-64 years), patients with anxious disorders 50±9.5 years (range 22-65 years) while patients with comorbidity of these two entities was at mean age of 54.5±4.5 years. The least common category of education was retired persons and respondents with university education for all three entities. Hospitalization duration for depression, anxiety, and comorbidity of these two disorders is highest for depression (47.1±9.7 days) and shortest in case of comorbidity (45.9±6.9 days). Conclusion: Depression and anxiety often coexist. When they occur in comorbidity, both anxiety and depression appear to be more severe. Severely depressed and anxious patients have reduced capacity to work and as such represents a considerable burden to the family and the community. Overview of depression, anxiety and the comorbidity of these two diagnoses (listed as primary diagnosis) in the baseline sample showed that there was most patients with depression (107 or 46.5%), followed by anxiety (71 or 30.9%) and comorbidity with 14 patients or 6.1%. Effective assessment, evaluation, diagnosis and treatment can lead to better treatment outcomes in primary care and improved quality of life.
1. Latas M, Trajković G, Starčević V. Prediktori psihijatrijskog komorbiditeta kod pacijenata sa paničnim poremećajem i agorafobijom Psihijatrija danas. 2008; 40(2): 163-173.
2. Adnađević S, Latas M. Komorbiditet paničnog poremećaja i somatskih oboljenja. Engrami – časopis za kliničku psihijatriju, psihologiju i granične discipline. 2004; 26(3-4): 23-28.
3. Latas M, Stojanović D, Mamula-Mijalković D, Batinić B. Psihopatologija i terapija komorbiditeta anksioznih i afektivnih poremećaja Engrami – časopis za kliničku psihijatriju, psihologiju i granične discipline. 2005; 27(1-2): 15-20.
4. Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety. 1996-1997; 4(4): 160-168.
5. Kaplan HI, Sadcok BJ, Sadock VA. Chomprehensive textbook of psychiatry. Philadelphia: Lippincott Wiliams and Wilkins, 2007: 528-581.
6. Nutt D, Argyropoulos S, Hood S, Potokar J. Generalized anxiety disorder: A comorbid disease. European neuropsychopharmacology. 2006; 16, Suppl 2: S109-18).
7. Aina Y, Susman JL. Understanding comorbidity with depression and anxiety disorders. J Am Osteopath Assoc. 2006 May; 106(5 Suppl 2): S9-14.
8. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope HG, Rounsaville BJ, Wittchen H. Challenges in operationalizing the DSM-IV clinical significance criterion. Arch Gen Psychiatry. 2004 Dec; 61(12): 1197-207.
9. Beck Arot T, Steer Robert A, Ciervo Carman A, Kabat M. Use of the Beck Anxiety and Depression Inventories for Primary Care with Medical Outpatients. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
10. Fava M, Rush AJ, Alpert JE. et al. Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression. Am J Psychiatry. 2008; 165: 342-351.
11. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry. 2005: 617-627.
12. U.S. Census Bureau Population Estimates by Demographic Characteristics. Table 2: Annual Estimates of the Population by Selected Age Groups and Sex for the United States: April 1, 2000 to July 1, 2004 (NC-EST2004-02) Source: Population Division, U.S. Census Bureau Release Date: June 9, 2005.http://www.census.gov/popest/national/asrh.).
13. Balestrieri M, Isola M, Quartaroli M, Roncolato M, Bellantuono C. Assessing mixed anxiety-depressive disorder. A national primary care survey. Psychiatry Res. 2010: 197-201.
14. Kruja J, Vyshka G. Avoiding Parental Distress When Discussing About SUDEP: the Albanian Experience. Med Arh. 2012 Jun; 66(3): 201-203. [DOI via Crossref] [DOI via Crossref] [Pubmed]
15. Licanin I, Fisekovic S, Babic S. Admission Rate of Patients with Most Common Psychiatric Disorders in Relation to Seasons and Climatic Factors During 2010/2011. Mat Soc Med. 2012 Jun; 24(2): 94-99. [DOI via Crossref]
16. Selimbasic Z, Sinanovic O, Avdibegovic E. Psychosocial Problems Among Children of Parents with Postratraumatic Stress Disorder. Med Arh. 2012; 66(5): in press.